Hyperlipidemia, diabetes mellitus type 2, and coronary heart disease have been associated
with being born small for gestational age (SGA). It has been reported that GH treatment …

Context: Low birth weight might increase risk of diabetes mellitus type 2 and metabolic
syndrome (MS). GH has insulin-antagonistic properties. Therefore, long-term follow-up of …

Context We previously reported that short, small for gestational age (SGA) children who
were born preterm have a lower body fat percentage and a higher blood pressure, insulin …

Background Long-term growth hormone (GH) treatments in short children born small for
gestational age (SGA) restore lipid metabolism, but also increase insulin resistance. The aim …

Several studies have demonstrated an association between low birth weight and impaired
insulin sensitivity or even type 2 diabetes mellitus (DM2) in later life. Growth hormone (GH) …

To assess the effects of long-term continuous GH treatment on body composition, blood
pressure (BP), and lipid metabolism in children with short stature born small for gestational …

Abstract Extended Abstract Low birth weight has been associated with impaired insulin
sensitivity, type 2 diabetes mellitus, hypertension and cardiovascular disease in later life. GH …

Abstract Background/Aims: An examination of the effects of up to 260 weeks of growth
hormone (GH) therapy on metabolic parameters in Japanese children born small for …

Context: GH treatment reduces insulin sensitivity (Si). For small-for-gestational-age (SGA)
subjects, who might have an increased risk to develop cardiovascular disease and type 2 …

Context: Previously we showed that pubertal children born small for gestational age (SGA)
with a poor adult height (AH) expectation can benefit from treatment with GH 1 mg/m2 per …